Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
Phase 2 Completed
55 enrolled 10 charts
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Phase 2 Recruiting
119 enrolled
AACER
Phase 2 Completed
53 enrolled
ECHO-07
Phase 2 Completed
42 enrolled 24 charts
ERLO-XIB
Phase 2 Unknown
64 enrolled
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Completed
37 enrolled 6 charts
Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
Phase 2 Completed
30 enrolled 16 charts
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Phase 2 Completed
34 enrolled 16 charts
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Phase 2 Completed
24 enrolled
Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Terminated
3 enrolled 8 charts
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 2 Completed
44 enrolled 9 charts
A Study of Tongue Conservation Surgery for Oral Tongue Cancer
Phase 2 Terminated
23 enrolled
MAESTRO HN
Phase 2 Completed
86 enrolled 11 charts
Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue
Phase 2 Unknown
30 enrolled
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery
Phase 2 Completed
55 enrolled 8 charts
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
Phase 2 Completed
6 enrolled
Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 2 Completed
30 enrolled
Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer
Phase 2 Withdrawn
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Phase 2 Completed
325 enrolled 15 charts
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
15 enrolled 8 charts
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
71 enrolled 8 charts
Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
9 enrolled 8 charts
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Phase 2 Completed
Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy
Phase 2 Withdrawn
Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck
Phase 2 Completed
144 enrolled
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 2 Unknown
46 enrolled